En savoir plus<\/a><\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":"
MI-mAbs, d\u00e9monstrateur pr\u00e9-industriel destin\u00e9 \u00e0 acc\u00e9l\u00e9rer la mise au point de nouveaux anticorps contre les cancers et les maladies inflammatoires, annonce aujourd\u2019hui la signature d\u2019un contrat de recherche avec Innate Pharma et Sanofi. MI-mAbs sera charg\u00e9 de r\u00e9aliser les \u00e9tudes permettant de d\u2019\u00e9valuer l\u2019efficacit\u00e9 et la s\u00e9curit\u00e9 des anticorps bisp\u00e9cifiques de nouvelle g\u00e9n\u00e9ration issus de la collaboration entre les deux industriels.<\/p>\n","protected":false},"author":1,"featured_media":8376,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9,13],"tags":[],"class_list":["post-16053","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites","category-nos-adherents"],"yoast_head":"\n
MI-mAbs signe un contrat de recherche portant sur l'\u00e9valuation d'anticorps bisp\u00e9cifiques in\u00e9dits co-d\u00e9velopp\u00e9s par Innate Pharma et Sanofi - MabDesign<\/title>\n<meta name=\"description\" content=\"MI-mAbs, d\u00e9monstrateur pr\u00e9-industriel destin\u00e9 \u00e0 acc\u00e9l\u00e9rer la mise au point de nouveaux anticorps contre les cancers et les maladies inflammatoires, annonce aujourd\u2019hui la signature d\u2019un contrat de recherche avec Innate Pharma et Sanofi. MI-mAbs sera charg\u00e9 de r\u00e9aliser les \u00e9tudes permettant de d\u2019\u00e9valuer l\u2019efficacit\u00e9 et la s\u00e9curit\u00e9 des anticorps bisp\u00e9cifiques de nouvelle g\u00e9n\u00e9ration issus de la collaboration entre les deux industriels.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MI-mAbs signe un contrat de recherche portant sur l'\u00e9valuation d'anticorps bisp\u00e9cifiques in\u00e9dits co-d\u00e9velopp\u00e9s par Innate Pharma et Sanofi - MabDesign\" \/>\n<meta property=\"og:description\" content=\"MI-mAbs, d\u00e9monstrateur pr\u00e9-industriel destin\u00e9 \u00e0 acc\u00e9l\u00e9rer la mise au point de nouveaux anticorps contre les cancers et les maladies inflammatoires, annonce aujourd\u2019hui la signature d\u2019un contrat de recherche avec Innate Pharma et Sanofi. MI-mAbs sera charg\u00e9 de r\u00e9aliser les \u00e9tudes permettant de d\u2019\u00e9valuer l\u2019efficacit\u00e9 et la s\u00e9curit\u00e9 des anticorps bisp\u00e9cifiques de nouvelle g\u00e9n\u00e9ration issus de la collaboration entre les deux industriels.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2016-06-21T13:46:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/logo_mimabs-lb.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1467\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"alexis.mathias@kairios.fr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"alexis.mathias@kairios.fr\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/\"},\"author\":{\"name\":\"alexis.mathias@kairios.fr\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\"},\"headline\":\"MI-mAbs signe un contrat de recherche portant sur l’\u00e9valuation d’anticorps bisp\u00e9cifiques in\u00e9dits co-d\u00e9velopp\u00e9s par Innate Pharma et Sanofi\",\"datePublished\":\"2016-06-21T13:46:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/\"},\"wordCount\":128,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/logo_mimabs-lb.jpg\",\"articleSection\":[\"Actualit\u00e9s\",\"Nos adh\u00e9rents\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/\",\"name\":\"MI-mAbs signe un contrat de recherche portant sur l'\u00e9valuation d'anticorps bisp\u00e9cifiques in\u00e9dits co-d\u00e9velopp\u00e9s par Innate Pharma et Sanofi - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/logo_mimabs-lb.jpg\",\"datePublished\":\"2016-06-21T13:46:04+00:00\",\"description\":\"MI-mAbs, d\u00e9monstrateur pr\u00e9-industriel destin\u00e9 \u00e0 acc\u00e9l\u00e9rer la mise au point de nouveaux anticorps contre les cancers et les maladies inflammatoires, annonce aujourd\u2019hui la signature d\u2019un contrat de recherche avec Innate Pharma et Sanofi. MI-mAbs sera charg\u00e9 de r\u00e9aliser les \u00e9tudes permettant de d\u2019\u00e9valuer l\u2019efficacit\u00e9 et la s\u00e9curit\u00e9 des anticorps bisp\u00e9cifiques de nouvelle g\u00e9n\u00e9ration issus de la collaboration entre les deux industriels.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/#primaryimage\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/logo_mimabs-lb.jpg\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/logo_mimabs-lb.jpg\",\"width\":1467,\"height\":450},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MI-mAbs signe un contrat de recherche portant sur l’\u00e9valuation d’anticorps bisp\u00e9cifiques in\u00e9dits co-d\u00e9velopp\u00e9s par Innate Pharma et Sanofi\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\",\"name\":\"alexis.mathias@kairios.fr\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"caption\":\"alexis.mathias@kairios.fr\"},\"sameAs\":[\"http:\/\/mabdesign.fr\"],\"url\":\"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MI-mAbs signe un contrat de recherche portant sur l'\u00e9valuation d'anticorps bisp\u00e9cifiques in\u00e9dits co-d\u00e9velopp\u00e9s par Innate Pharma et Sanofi - MabDesign","description":"MI-mAbs, d\u00e9monstrateur pr\u00e9-industriel destin\u00e9 \u00e0 acc\u00e9l\u00e9rer la mise au point de nouveaux anticorps contre les cancers et les maladies inflammatoires, annonce aujourd\u2019hui la signature d\u2019un contrat de recherche avec Innate Pharma et Sanofi. MI-mAbs sera charg\u00e9 de r\u00e9aliser les \u00e9tudes permettant de d\u2019\u00e9valuer l\u2019efficacit\u00e9 et la s\u00e9curit\u00e9 des anticorps bisp\u00e9cifiques de nouvelle g\u00e9n\u00e9ration issus de la collaboration entre les deux industriels.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/","og_locale":"en_US","og_type":"article","og_title":"MI-mAbs signe un contrat de recherche portant sur l'\u00e9valuation d'anticorps bisp\u00e9cifiques in\u00e9dits co-d\u00e9velopp\u00e9s par Innate Pharma et Sanofi - MabDesign","og_description":"MI-mAbs, d\u00e9monstrateur pr\u00e9-industriel destin\u00e9 \u00e0 acc\u00e9l\u00e9rer la mise au point de nouveaux anticorps contre les cancers et les maladies inflammatoires, annonce aujourd\u2019hui la signature d\u2019un contrat de recherche avec Innate Pharma et Sanofi. MI-mAbs sera charg\u00e9 de r\u00e9aliser les \u00e9tudes permettant de d\u2019\u00e9valuer l\u2019efficacit\u00e9 et la s\u00e9curit\u00e9 des anticorps bisp\u00e9cifiques de nouvelle g\u00e9n\u00e9ration issus de la collaboration entre les deux industriels.","og_url":"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/","og_site_name":"MabDesign","article_published_time":"2016-06-21T13:46:04+00:00","og_image":[{"width":1467,"height":450,"url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/logo_mimabs-lb.jpg","type":"image\/jpeg"}],"author":"alexis.mathias@kairios.fr","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"alexis.mathias@kairios.fr","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/"},"author":{"name":"alexis.mathias@kairios.fr","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135"},"headline":"MI-mAbs signe un contrat de recherche portant sur l’\u00e9valuation d’anticorps bisp\u00e9cifiques in\u00e9dits co-d\u00e9velopp\u00e9s par Innate Pharma et Sanofi","datePublished":"2016-06-21T13:46:04+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/"},"wordCount":128,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/logo_mimabs-lb.jpg","articleSection":["Actualit\u00e9s","Nos adh\u00e9rents"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/","url":"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/","name":"MI-mAbs signe un contrat de recherche portant sur l'\u00e9valuation d'anticorps bisp\u00e9cifiques in\u00e9dits co-d\u00e9velopp\u00e9s par Innate Pharma et Sanofi - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/#primaryimage"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/logo_mimabs-lb.jpg","datePublished":"2016-06-21T13:46:04+00:00","description":"MI-mAbs, d\u00e9monstrateur pr\u00e9-industriel destin\u00e9 \u00e0 acc\u00e9l\u00e9rer la mise au point de nouveaux anticorps contre les cancers et les maladies inflammatoires, annonce aujourd\u2019hui la signature d\u2019un contrat de recherche avec Innate Pharma et Sanofi. MI-mAbs sera charg\u00e9 de r\u00e9aliser les \u00e9tudes permettant de d\u2019\u00e9valuer l\u2019efficacit\u00e9 et la s\u00e9curit\u00e9 des anticorps bisp\u00e9cifiques de nouvelle g\u00e9n\u00e9ration issus de la collaboration entre les deux industriels.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/#primaryimage","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/logo_mimabs-lb.jpg","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/logo_mimabs-lb.jpg","width":1467,"height":450},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/mi-mabs-signe-un-contrat-de-recherche-portant-sur-levaluation-danticorps-bispecifiques-inedits-co-developpes-par-innate-pharma-et-sanofi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"MI-mAbs signe un contrat de recherche portant sur l’\u00e9valuation d’anticorps bisp\u00e9cifiques in\u00e9dits co-d\u00e9velopp\u00e9s par Innate Pharma et Sanofi"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135","name":"alexis.mathias@kairios.fr","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","caption":"alexis.mathias@kairios.fr"},"sameAs":["http:\/\/mabdesign.fr"],"url":"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/16053","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=16053"}],"version-history":[{"count":0,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/16053\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media\/8376"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=16053"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=16053"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=16053"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}